Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01861132
Other study ID # NexValid13
Secondary ID
Status Completed
Phase
First received
Last updated
Start date May 2013
Est. completion date February 2014

Study information

Verified date June 2021
Source Oslo University Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Blood pressure and cardiac output can be measured invasively in pregnant women. Non-invasive monitoring devices are desirable, but until now, no equipment has proven validity. This study aims at validating the non-invasive monitoring device NexFin (second generation Finometer) in pregnant women.


Description:

Validation will be a direct beat-to-beat comparison of data from NexFin and the invasive measurements of blood pressure and calibrated cardiac output as an integrated part of LiDCO Plus. Both comparison of absolute values and the two different devices trending abilities will be analyzed.


Recruitment information / eligibility

Status Completed
Enrollment 20
Est. completion date February 2014
Est. primary completion date February 2014
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 50 Years
Eligibility Inclusion Criteria: - Healthy singleton pregnancies at term scheduled for cesarean delivery Exclusion Criteria: - Twins, or multiple gestation, pre-eclampsia, gestational hypertension - Reynaud phenomenon

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Norway Oslo University Hospital Oslo

Sponsors (1)

Lead Sponsor Collaborator
Oslo University Hospital

Country where clinical trial is conducted

Norway, 

References & Publications (1)

Omenås IN, Tronstad C, Rosseland LA. Accuracy and trending abilities of finger plethysmographic blood pressure and cardiac output compared to invasive measurements during caesarean delivery in healthy women: an observational study. BMC Anesthesiol. 2020 J — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Systolic blood pressure Comparison of beat-to-beat data 15 minutes
Secondary Cardiac output Comparing beat-to-beat data of cardiac output 15 minutes